Unlock stock picks and a broker-level newsfeed that powers Wall Street.
LSE - Delayed Quote GBp

Diaceutics PLC (DXRX.L)

Compare
112.50
-2.50
(-2.17%)
At close: April 4 at 4:38:16 PM GMT+1
Loading Chart for DXRX.L
  • Previous Close 115.00
  • Open 115.50
  • Bid 110.00 x --
  • Ask 115.00 x --
  • Day's Range 110.00 - 116.75
  • 52 Week Range 95.00 - 151.00
  • Volume 110,524
  • Avg. Volume 106,747
  • Market Cap (intraday) 97.2M
  • Beta (5Y Monthly) 0.79
  • PE Ratio (TTM) --
  • EPS (TTM) -0.03
  • Earnings Date May 2, 2025 - May 6, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 199.40

Diaceutics PLC, a diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. The company offers DXRX, a diagnostic commercialisation platform for precision medicine that integrates multiple pipelines of diagnostic testing data from network of laboratories. It also provides DXRX data solutions, including DXRX Signal, which delivers an actionable alert of a testing behavior for making treatment decisions; DXRX Physician Mapping that examines physician testing behavior using patient level data to determine testing rates, methodology, and the physician to lab relationship; DXRX Lab Mapping that offers insights into labs currently testing patients diagnosed with a specific disease or biomarker; and DXRX Disease Testing Rate Tracker, which delivers biomarker testing rate reports. In addition, the company offers professional services, such as market landscape, implementation, and consulting services. Diaceutics PLC was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.

www.diaceutics.com

184

Full Time Employees

December 31

Fiscal Year Ends

Recent News: DXRX.L

View More

Performance Overview: DXRX.L

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .

YTD Return

DXRX.L
10.36%
FTSE 100 (^FTSE)
1.44%

1-Year Return

DXRX.L
7.14%
FTSE 100 (^FTSE)
0.99%

3-Year Return

DXRX.L
10.84%
FTSE 100 (^FTSE)
6.56%

5-Year Return

DXRX.L
12.45%
FTSE 100 (^FTSE)
48.74%

Compare To: DXRX.L

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: DXRX.L

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    95.09M

  • Enterprise Value

    79.47M

  • Trailing P/E

    --

  • Forward P/E

    0.78

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.64

  • Price/Book (mrq)

    2.45

  • Enterprise Value/Revenue

    3.05

  • Enterprise Value/EBITDA

    55.97

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -10.90%

  • Return on Assets (ttm)

    -6.06%

  • Return on Equity (ttm)

    -7.13%

  • Revenue (ttm)

    26.09M

  • Net Income Avi to Common (ttm)

    -2.85M

  • Diluted EPS (ttm)

    -0.03

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    16.75M

  • Total Debt/Equity (mrq)

    2.93%

  • Levered Free Cash Flow (ttm)

    1.41M

Research Analysis: DXRX.L

View More

Company Insights: DXRX.L

Research Reports: DXRX.L

View More

People Also Watch